May 22, 2018 / 6:16 AM / a month ago

BRIEF-Circassia Pharma presents positive Duaklir and Tudorza data

May 22 (Reuters) - Circassia Pharmaceuticals PLC:

* CIRCASSIA PHARMA PLC - POSITIVE DATA PRESENTED AT 2018 ATS CONFERENCE

* ANNOUNCES POSITIVE DATA PRESENTED AT 2018 AMERICAN THORACIC SOCIETY CONFERENCE FROM TUDORZA® PHASE IV AND DUAKLIR® PHASE III STUDIES

* WE LOOK FORWARD TO REGULATORY FILINGS IN COMING WEEKS SEEKING US APPROVAL FOR DUAKLIR® AND AN EXTENSION TO TUDORZA®’S US PRESCRIBING INFORMATION TO INCLUDE ASCENT DATA Source text for Eikon: Further company coverage: (Reporting By London Bureau)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below